טוען...
Is radioiodine administration in patients with papillary thyroid multifocal microcarcinoma unnecessary?
Radioiodine (RAI) has played a crucial role in differentiated thyroid cancer treatment for more than 60years. However, the use of RAI administration in patients with papillary thyroid microcarcinoma (even multifocal) is now being widely discussed and often not recommended. In accordance with Europea...
שמור ב:
| הוצא לאור ב: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Bioscientifica Ltd
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4870506/ https://ncbi.nlm.nih.gov/pubmed/27252861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-15-0138 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|